IRIS UniCatt

Ponziani, Francesca Romana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.457
AS - Asia 6.747
EU - Europa 5.521
SA - Sud America 1.273
AF - Africa 157
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 16
Totale 21.192
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.227
SG - Singapore 3.075
CN - Cina 1.493
DE - Germania 1.395
IT - Italia 1.062
BR - Brasile 1.046
SE - Svezia 876
VN - Vietnam 723
FR - Francia 547
IE - Irlanda 304
IN - India 254
GB - Regno Unito 253
UA - Ucraina 252
FI - Finlandia 212
HK - Hong Kong 200
ID - Indonesia 196
JP - Giappone 188
RU - Federazione Russa 132
CA - Canada 114
AR - Argentina 101
TR - Turchia 95
PL - Polonia 91
BD - Bangladesh 82
NL - Olanda 81
IQ - Iraq 74
KR - Corea 65
MX - Messico 63
BE - Belgio 52
ZA - Sudafrica 52
ES - Italia 44
SA - Arabia Saudita 41
AT - Austria 38
PK - Pakistan 36
CZ - Repubblica Ceca 31
EC - Ecuador 31
IR - Iran 29
CH - Svizzera 23
PH - Filippine 23
AE - Emirati Arabi Uniti 22
LT - Lituania 22
CI - Costa d'Avorio 21
PY - Paraguay 19
CO - Colombia 18
PE - Perù 18
UZ - Uzbekistan 18
AU - Australia 17
EG - Egitto 17
IL - Israele 17
RO - Romania 17
JO - Giordania 16
MA - Marocco 14
VE - Venezuela 14
NP - Nepal 13
CL - Cile 11
UY - Uruguay 11
AL - Albania 10
GR - Grecia 10
EU - Europa 9
KE - Kenya 9
KZ - Kazakistan 9
MY - Malesia 9
SN - Senegal 9
CR - Costa Rica 8
ET - Etiopia 8
AZ - Azerbaigian 7
DZ - Algeria 7
KG - Kirghizistan 7
LB - Libano 7
PA - Panama 7
PT - Portogallo 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
JM - Giamaica 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
TH - Thailandia 6
TZ - Tanzania 6
BH - Bahrain 5
GT - Guatemala 5
HN - Honduras 5
MD - Moldavia 5
NO - Norvegia 5
TN - Tunisia 5
BG - Bulgaria 4
BY - Bielorussia 4
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
OM - Oman 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
DK - Danimarca 3
GE - Georgia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
QA - Qatar 3
Totale 21.144
Salva come PNG Salva come JPEG
Città #
Singapore 1.769
Chandler 848
San Jose 765
Ashburn 710
Beijing 302
Dublin 300
Ho Chi Minh City 262
New York 256
Rome 238
Los Angeles 221
Dallas 195
Hefei 186
Hong Kong 183
The Dalles 183
Lauterbourg 182
Tokyo 174
Jakarta 171
Milan 158
San Mateo 150
Hanoi 145
Jacksonville 144
Cattolica 125
Chicago 121
Munich 116
Ann Arbor 115
Boston 114
Council Bluffs 111
St Louis 111
Frankfurt am Main 110
Wilmington 101
São Paulo 99
Nanjing 89
Marseille 88
Helsinki 85
Moscow 83
Princeton 73
Santa Clara 62
Boardman 60
Buffalo 60
Nürnberg 57
Kent 55
Seoul 55
Redwood City 53
Houston 52
Izmir 52
Turku 50
Brussels 47
Hyderabad 47
Warsaw 47
Paris 46
Zhengzhou 45
Da Nang 43
Dearborn 43
Orem 43
Lawrence 42
Nuremberg 42
Woodbridge 41
San Francisco 39
Amsterdam 37
Bremen 37
Brooklyn 36
London 36
Seattle 36
Fairfield 35
Stockholm 35
Atlanta 33
Denver 33
Nanchang 32
Toronto 32
Montreal 31
Rio de Janeiro 31
Shanghai 31
Augusta 30
Haiphong 30
Johannesburg 30
Lappeenranta 29
Phoenix 29
Tianjin 29
Baghdad 28
Guangzhou 28
Hangzhou 28
Pune 28
Chennai 25
Poplar 25
Shenyang 25
Belo Horizonte 23
Düsseldorf 23
Kraków 23
North Bergen 23
Norwalk 22
Abidjan 21
Changsha 21
Manchester 21
Hebei 20
Hải Dương 20
Lancaster 20
Mumbai 19
Porto Alegre 19
Dhaka 18
Guarulhos 18
Totale 11.314
Salva come PNG Salva come JPEG
Nome #
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 341
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 332
Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship 244
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 231
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 215
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis 199
Biomarkers of low-grade inflammation in primary varicose veins of the lower limbs 196
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 191
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 186
Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit 186
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 186
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 185
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 173
New modalities of ultrasound-based intima-media thickness, arterial stiffness and non-coronary vascular calcifications detection to assess cardiovascular risk 172
Intestinal barrier in human health and disease 165
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 163
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 161
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 160
Use and indications of cholestyramine and bile acid sequestrants 159
Diagnosis of bowel diseases: the role of imaging and ultrasonography 158
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 157
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. 156
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota 154
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 152
Gut microbiota and metabolic syndrome 151
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 147
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Diet-Induced Alterations in Gut Microbiota Composition and Function 147
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends 146
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 146
Update on the Role of Rifaximin in Digestive Diseases 145
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 141
The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma 141
Diagnosis and treatment of small intestinal bacterial overgrowth 141
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis 140
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 140
Physiology and pathophysiology of liver lipid metabolism 139
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 139
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms 138
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 137
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 137
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 136
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 135
Morphological and functional consequences of transradial coronary angiography on the radial artery: implications for its use as a bypass conduit 133
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients 133
International consensus statement on microbiome testing in clinical practice 132
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 130
Use and indications of cholestyramine and bile acid sequestrants 130
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 130
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management 129
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 128
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 128
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease - A comprehensive narrative review 125
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 125
Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease 124
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 124
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 124
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 123
Lynch Syndrome and Thyroid Nodules: A Single Center Experience 122
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? 122
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 120
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective 120
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 119
Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results 118
Hepatocellular-Carcinoma-Derived Organoids: Innovation in Cancer Research 118
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy 117
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 117
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports 117
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients 117
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 117
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease 116
GUT MICROBIOTA IN PRIMARY SCLEROSING CHOLANGITIS: FROM PROGNOSTIC ROLE TO THERAPEUTIC IMPLICATIONS 116
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 116
Vaccine Responses in Patients with Liver Cirrhosis: From the Immune System to the Gut Microbiota 115
Regorafenib: a promising treatment for hepatocellular carcinoma 115
Morphological and functional consequences of transradial coronary angiography on the radial artery: Implications for its use as a bypass conduit 115
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies 114
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 111
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation 111
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 111
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 110
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 109
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma 109
Clinical impact of comorbidities in an Italian NAFLD cohort 108
Mitochondria-Derived Vesicles, Sterile Inflammation, and Pyroptosis in Liver Cancer: Partners in Crime or Innocent Bystanders? 108
Meta-Analysis: Inverse Association Between Helicobacter pylori Infection and Eosinophilic Oesophagitis 108
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 108
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 108
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 108
Effect of liver transplantation on intestinal permeability and correlation with infection episodes 108
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis 107
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 107
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties 107
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 106
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 106
Totale 14.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 62 149 24
2021/2022957 75 51 17 65 64 32 14 181 38 62 183 175
2022/20232.545 306 288 180 360 146 332 142 247 295 55 110 84
2023/20241.664 91 413 70 86 73 253 116 37 27 88 164 246
2024/20253.718 92 87 307 90 284 132 152 175 445 475 841 638
2025/20269.446 1.355 343 695 1.150 1.725 471 1.805 517 715 670 0 0
Totale 21.519